Safety and prognostic impact of prophylactic laparoscopic superior mesenteric vein (No. 14v) lymph node dissection for lower-third gastric cancer: a propensity score-matched case–control study
- 147 Downloads
To investigate oncologic efficacy of prophylactic laparoscopic superior mesenteric vein (No. 14v) lymph node (LN) dissection for lower-third gastric cancer (LTGC).
We retrospectively collected data from 757 patients who underwent laparoscopic-assisted distal gastrectomy for LTGC. Of these patients, 102 underwent 14v LN dissection (14vD+ group), and the remaining 655 patients did not undergo 14v LN dissection (14vD− group). The outcomes were compared using a 1:1 propensity score matching method.
After matching, 93 patients from the 14vD+ group and 93 patients from the 14vD− group with similar clinicopathological characteristics were compared. Before matching, the overall survival (OS) was similar between the two groups (P = 0.742). After matching, the OS was greater in the 14vD+ group (P = 0.025). The status of 14v dissection was not a significant prognostic factor in the survival analyses, both before and after matching. However, a stratified analysis according to the independent factors in the OS showed that the OS in the 14vD+ group was higher than that in the 14vD− group for cT2-3 patients after matching. The forest plot of OS showed that after matching the 14vD+ group had a significantly higher 3-year OS rate than the 14vD− group in cT2-3 patients. The distribution of the therapeutic index demonstrated that the index of 14v LN was similar to those of Nos. 1, 7, 8a, 9, and 11p after matching.
Adding laparoscopic 14v dissection for laparoscopic-assisted radical distal gastrectomy was safe and might improve the OS for clinically advanced LTGC without serosal invasion.
KeywordsGastric carcinoma No. 14v lymph node Lymphadenectomy Prognosis Propensity score matching
This study is supported by National Key Clinical Specialty Discipline Construction program of China (No. 649), and Scientific and technological innovation joint capital projects of Fujian Province (2016Y9031).
Compliance with ethical standards
Qi-Yue Chen, Chao-Hui Zheng, Ping Li, Jian-Wei Xie, Jia-Bin Wang, Jian-Xian Lin, Jun Lu, Long-Long Cao, Mi Lin, Ru-Hong Tu, Ze-Ning Huang, Ju-Li Lin and Chang-Ming Huang have no conflicts of interest or financial ties to disclose.
- 4.Okines A, Verheij M, Allum W, Cunningham D, Cervantes A (2010) Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 20(suppl 4):ii41–ii42Google Scholar
- 11.Bang WE, Joo J, Kim YW, Reim D, Ji YP, Hong MY et al (2013) Improved survival after adding dissection of the superior mesenteric vein lymph node (14 v) to standard D2 gastrectomy for advanced distal gastric cancer. Surgery 155:408–416Google Scholar
- 12.Blouhos K, Boulas KA, Tsalis K, Hatzigeorgiadis A (2015) Right-sided bursectomy as an access plane for aesthetic resection of the posterior leaf of the lesser sac from the head of the pancreas en block with the No. 6 and 14v lymph nodes in advanced lower third gastric cancer. Surgery 158:1742CrossRefPubMedGoogle Scholar
- 13.Liang Y, Wu L, Wang X, Ding X, Liu H, Li B et al (2015) Positive impact of adding No.14v lymph node to D2 dissection on survival for distal gastric cancer patients after surgery with curative intent. Chin. J Cancer Res 27:580Google Scholar